Ascendis Pharma A (ASND) EBT Margin Growth (3y) (2017 - 2026)
Ascendis Pharma A (ASND) EBT Margin Growth (3y) (2017 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBT Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
49,756.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
441.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Ascendis Pharma A |
2.75 Bn |
2.08 Bn |
268.20 Mn |
30,681.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
30,681.00 |
| Dec 31, 2025 |
87,443.00 |
| Sep 30, 2025 |
107,924.00 |
| Jun 30, 2025 |
129,873.00 |
| Mar 31, 2025 |
174,178.00 |
| Dec 31, 2024 |
12,205.00 |
| Sep 30, 2024 |
704,884.00 |
| Jun 30, 2024 |
1.29 Mn |
| Mar 31, 2024 |
830,873.00 |
| Dec 31, 2023 |
18,576.00 |
| Sep 30, 2023 |
408,001.00 |
| Jun 30, 2023 |
636,111.00 |
| Mar 31, 2023 |
252,282.00 |
| Dec 31, 2022 |
-68,382.00 |
| Sep 30, 2022 |
1,624.00 |
| Jun 30, 2022 |
51,559.00 |
| Mar 31, 2022 |
-84,246.00 |
| Dec 31, 2021 |
-469.00 |
| Sep 30, 2021 |
-721,843.00 |
| Jun 30, 2021 |
11.39 Mn |
